Yeah, I wonder how much the shorts actually pay attention to things like burn rate, cash, partnerships etc. They probably just assume, "Oh here's a small biotech with handful of employees, let's have our way."

Every indication is that Aspire is a great partner, offered very favorable terms to CTIX, and continues to buy, not sell as others often posit.